Related Experiment Videos
Diester derivatives as apomorphine prodrugs
Journal of Medicinal Chemistry
|May 1, 1976
Summary
New apomorphine diesters act as prodrugs, releasing active apomorphine in the brain. These prodrugs offer a prolonged therapeutic effect compared to apomorphine alone, with duration linked to ester size and hydrolysis rate.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- Apomorphine is a dopamine agonist used clinically.
- Developing effective prodrugs can improve drug delivery and duration of action.
- Understanding prodrug metabolism is crucial for therapeutic efficacy.
Purpose of the Study:
- To synthesize apomorphine diesters as potential prodrugs.
- To evaluate the in vivo conversion of these diesters to apomorphine.
- To assess the pharmacological effects and duration of action of the synthesized prodrugs.
Main Methods:
- Synthesis of apomorphine diester series.
- In vivo administration and detection of apomorphine in brain tissue.
- Assessment of stereotyped gnawing behavior and unilateral rotation.
- In vitro hydrolysis assays using liver extracts.
Main Results:
- All synthesized diesters were converted in vivo to free apomorphine.
- Apomorphine diesters induced behavioral effects similar to apomorphine but with prolonged action.
- Duration of action correlated with ester substituent size and inversely with hydrolysis rate.
- Hydrolysis rate decreased with increasing steric hindrance.
Conclusions:
- Apomorphine diesters function effectively as prodrugs.
- The prolonged duration of action is attributed to reduced hydrolysis rates.
- Steric hindrance at acyl carbon atoms influences ester hydrolysis and prolongs efficacy.